| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |